Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 10 results.
User Information
Export Records
  1. 1.   Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis
  2. Francesconi, A.; Kasai, M.; Petraitiene, R.; Petraitis, V.; Kelaher, A. M.; Schaufele, R.; Hope, W. W.; Shea, Y. R.; Bacher, J.; Walsh, T. J.
  3. Journal of Clinical Microbiology. 2006, Jul; 44(7): 2475-2480.
  1. 2.   Peyer patches are not required for acute graft-versus-host disease after myeloablative conditioning and murine allogeneic bone marrow transplantation
  2. Welniak, L. A.; Kuprash, D. V.; Tumanov, A. V.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Sun, K.; Nedospasov, S. A.; Murphy, W. J.
  3. Blood. 2006, JAN 1; 107(1): 410-412.
  1. 3.   Antibodies to CD40 promote dendritic cell recovery and anti-tumor effects after syngeneic bone marrow transplant (BMT)
  2. Welniak, L. A.; Berner, V.; Blazar, B. R.; Wiltrout, R. H.; Murphy, W. J.
  3. Blood. 2005, NOV 16; 106(11, Part 1): 379A, Abstract 1305-379A, Abstract 1305.
  1. 4.   Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity
  2. Sun, K.; Wilkins, D. E. C.; Anver, M. R.; Sayers, T. J.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Weiniak, L. A.; Murphy, W. J.
  3. Blood. 2005, NOV 1; 106(9): 3293-3299.
  1. 5.   Ex vivo expanded murine bone marrow cells with a multiple cytokine cocktail retain long-term hematopoietic reconstitution potentials
  2. Yang, Q. E.; Fong, S. E.; Li, K. G.; Gonda, M. A.; Tobin, G. J.
  3. Medical Science Monitor. 2005, JUN; 11(6): BR154-BR161.
  1. 6.   Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib
  2. Sun, K.; Welniak, L. A.; Panoskaltsis-Mortari, A.; O'Shaughnessy, M. J.; Liu, H. Y.; Barao, I.; Riordan, W.; Sitcheran, R.; Wysocki, C.; Serody, J. S.; Blazar, B. R.; Sayers, T. J.; Murphy, W. J.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(21): 8120-8125.
  1. 7.   The absence of Peyer's patches or host TNF-alpha does not affect GVHD progression in an allogeneic BMT model using extensive conditioning regimens
  2. Welniak, L. A.; Kuprash, D. V.; Tumanov, A. V.; Sun, K.; Stull, S. W.; Anver, M. R.; Nedospasov, S. A.; Murphy, W. J.
  3. Biology of Blood and Marrow Transplantation. 2004 10(2, Suppl. 1): 52-52.
  1. 8.   PS-341 administration inhibits acute graft-versus-host disease and preserves graft-versus-tumor after allogeneic BMT in advanced tumor-bearing mice
  2. Sun, K.; Welniak, L. A.; Wilkins, D.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Sayers, T. J.; Murphy, W. J.
  3. Blood. 2003 102(11, Part 1): 192A-192A.
  1. 9.   NK inhibitory-receptor blockade for purging of leukemia: Effects on hematopoietic reconstitution
  2. Koh, C. Y.; Raziuddin, A.; Welniak, L. A.; Blazar, B. R.; Bennett, M.; Murphy, W. J.
  3. Biology of Blood and Marrow Transplantation. 2002 8(1): 17-25.
  1. 10.   Adoptive cellular immunotherapy: NK cells and bone marrow transplantation
  2. Koh, C. Y.; Welniak, L. A.; Murphy, W. J.
  3. Histology and Histopathology. 2000 15(4): 1201-1210.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel